8-(4,4-difluorocyclohexyl)-6-(2,4-dioxo-1,3-diazinan-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile
C17H16F2N6O2 — CID 171368317
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-(4,4-difluorocyclohexyl)-6-(2,4-dioxo-1,3-diazinan-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile
8-(4,4-difluorocyclohexyl)-6-(2,4-dioxo-1,3-diazinan-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile (PubChem CID 171368317) has the molecular formula C17H16F2N6O2 and a molecular weight of 374.35 g/mol. Its IUPAC name is 8-(4,4-difluorocyclohexyl)-6-(2,4-dioxo-1,3-diazinan-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile.
Molecular Properties
| Compound Name | 8-(4,4-difluorocyclohexyl)-6-(2,4-dioxo-1,3-diazinan-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile |
|---|---|
| PubChem CID | 171368317 |
| Molecular Formula | C17H16F2N6O2 |
| Molecular Weight | 374.35 g/mol |
| Exact Mass | 374.13 |
| IUPAC Name | 8-(4,4-difluorocyclohexyl)-6-(2,4-dioxo-1,3-diazinan-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile |
| SMILES | N#Cc1cnc2c(C3CCC(F)(F)CC3)cc(C3CNC(=O)NC3=O)nn12 |
| InChI | InChI=1S/C17H16F2N6O2/c18-17(19)3-1-9(2-4-17)11-5-13(12-8-22-16(27)23-15(12)26)24-25-10(6-20)7-21-14(11)25/h5,7,9,12H,1-4,8H2,(H2,22,23,26,27) |
| InChIKey | LLOLEYQEMUDXNT-UHFFFAOYSA-N |
| XLogP | 1.82 |
| TPSA | 112.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 374.35 |
| LogP ≤ 5 | 1.82 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171368317 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.